Chinese Journal of Tissue Engineering Research ›› 2026, Vol. 30 ›› Issue (19): 4867-4872.doi: 10.12307/2026.250

Previous Articles     Next Articles

Inhibitory effect of complement 1q/tumor necrosis factor-related protein 4 on 3T3-L1 preadipocyte differentiation

Maireyanmu·Rozi, Wang Hongping, Zhang Cuiping, Xia Juan, Shen Tian, Lei Tao, Lu Jun, Gao Jie   

  1. Putuo Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China
  • Received:2025-09-05 Accepted:2025-11-28 Online:2026-07-08 Published:2026-02-13
  • Contact: Gao Jie, MS, Attending physician, Putuo Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China
  • About author:Maireyanmu·Rozi, MS, Putuo Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China
  • Supported by:
    Putuo District Health System Science and Technology Innovation Project, No. ptkwws202417 (to GJ); Putuo District Health System Science and Technology Innovation Project, No. ptkwws202003 (to LT); Putuo District Health System Science and Technology Innovation Project, No. ptkwws202302 (to LJ); Putuo District Clinical Specialty, No. 2024tszk02 (to LJ); Putuo District Clinical Specialty, No. 2020tszk01 (to LT); Shanghai Municipal Health Commission Scientific Research Project, No. 202240309 (to LJ) 

Abstract: BACKGROUND: Adipocyte differentiation is a complex biological process involving the transformation of preadipocytes into mature adipocytes. This process plays a key role in the development and progression of obesity and related metabolic diseases. In recent years, the complement C1q/tumor necrosis factor-related protein family, as a new member of the adipokine family, has become a research hotspot in the field of metabolic regulation.
OBJECTIVE: To investigate the effect of complement 1q/tumor necrosis factor-related protein 4 on the differentiation of 3T3-L1 preadipocytes and its underlying mechanism. 
METHODS: The CCK-8 assay was used to determine the effects of different concentrations of complement 1q/tumor necrosis factor-related protein 4 on the viability of 3T3-L1 preadipocytes, and a safe concentration was selected for intervention. 3T3-L1 preadipocytes were divided into a control group, an inducer group, and a complement 1q/tumor necrosis factor-related protein 4 group. 3T3-L1 preadipocytes were first contact-inhibited for 2 days, followed by adipogenic inducer and complement 1q/tumor necrosis factor-related protein 4 treatment. On day 10 of differentiation, lipid droplet formation was observed using Oil Red O staining. The mRNA and protein expression levels of CCAAT/enhancer binding protein α, peroxisome proliferator-activated receptor γ, and fatty acid binding protein 4 were determined by RT-qPCR and western blot assay. Intracellular triglyceride and total cholesterol levels were measured using triglyceride and total cholesterol detection kits.
RESULTS AND CONCLUSION: The safe maximum concentration of complement 1q/tumor necrosis factor-related protein 4 without toxicity to 3T3-L1 preadipocytes was 1 000 ng/mL. Compared with the control group, the inducer group showed increased intracellular lipid droplet formation, elevated triglyceride and total cholesterol levels (P < 0.05), and significantly upregulated mRNA and protein expression levels of CCAAT/enhancer binding protein α, peroxisome proliferator-activated receptor γ, and fatty acid binding protein 4 (P < 0.05). Compared with the inducer group, the complement 1q/tumor necrosis factor-related protein 4 group showed reduced intracellular lipid droplet formation, lower triglyceride and total cholesterol levels (P < 0.05). The mRNA and protein expression levels of CCAAT/enhancer binding protein α, peroxisome proliferator-activated receptor γ, and fatty acid binding protein 4 were significantly downregulated (P < 0.05). These results suggest that complement 1q/tumor necrosis factor-related protein 4 inhibits the differentiation of preadipocytes into mature adipocytes, and its mechanism of action may be related to downregulating the expression of CCAAT/enhancer binding protein α, peroxisome proliferator-activated receptor γ, and fatty acid binding protein 4.

Key words: CTRP4, adipose differentiation, 3T3-L1 preadipocytes, obesity, adipogenesis, metabolic disorders, lipid accumulation, metabolic imbalance

CLC Number: